Journal article icon

Journal article

Cardiovascular disease incidence rates: a study using routinely collected health data

Abstract:
BACKGROUND: There is substantial evidence that systemic anticancer therapies and radiotherapy can increase the long-term risk of cardiovascular disease (CVD). Optimal management decisions for cancer patients therefore need to take into account the likely risks from a proposed treatment option, as well as its likely benefits. For CVD, the magnitude of the risk depends on the incidence of the disease in the general population to which the patient belongs, including variation with age and sex, as well as on the treatment option under consideration. The aim of this paper is to provide estimates of CVD incidence rates in the general population of England for use in cardio-oncology and in other relevant clinical, research and health policy contexts. METHODS: We studied a population-based representative cohort, consisting of 2,633,472 individuals, derived by electronic linkage of records from primary care with those of admitted-patient care in England during April 1, 2010, to April 1, 2015. From 38 individual CVDs available via the linked dataset we identified five relevant categories of CVD whose risk may be increased by cancer treatments: four of heart disease and one of stroke. RESULTS: We calculated incidence rates by age-group and sex for all relevant CVD categories combined, for the four relevant categories of heart disease combined, and for the five relevant CVD categories separately. We present separate incidence rates for all 38 individual CVDs available via the linked dataset. We also illustrate how our data can be used to estimate absolute CVD risks in a range of people with Hodgkin lymphoma treated with chemotherapy and radiotherapy. CONCLUSIONS: Our results provide population-based CVD incidence rates for a variety of uses, including the estimation of absolute risks of CVD from cancer treatments, thus helping patients and clinicians to make appropriate individualized cancer treatment decisions. Graphical Abstract: Cardiovascular incidence rates for use in cardio-oncology and elsewhere: A presentation of age- and sex-specific cardiovascular disease (CVD) incidence rates for use in calculation of absolute cardiovascular risks of cancer treatments, and in other clinical, research and health policy contexts. Abbreviations - CVD: cardiovascular disease; y: years.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1186/s40959-023-00189-8

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-4835-4153
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4046-0573
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7307-7488
More by this author
Role:
Author
ORCID:
0000-0001-7873-6972


More from this funder
Funder identifier:
10.13039/100014013
Grant:
MR/VO33867/1
More from this funder
Funder identifier:
10.13039/501100000289
Grant:
C8225/A21133
More from this funder
Funder identifier:
10.13039/501100000769


Publisher:
BioMed Central
Journal:
Cardio-Oncology More from this journal
Volume:
9
Issue:
1
Pages:
41-41
Article number:
41
Publication date:
2023-11-15
DOI:
EISSN:
2057-3804
ISSN:
2057-3804


Language:
English
Keywords:
Pubs id:
1573461
Local pid:
pubs:1573461
Source identifiers:
W4388704409
Deposit date:
2026-06-04
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP